1 active trials 1 recruiting 2 disease areas
| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT07033598 | Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia | Leukemia, Myelomonocytic, Chronic | Recruiting | 2026-08-18 |
Leukemia (1) · MDS/MPN Overlap (1)